Polymers in Medicine

Polim. Med.
Scopus CiteScore: 3.5 (CiteScore Tracker 3.6)
Index Copernicus (ICV 2023) – 121.14
MEiN – 70
ISSN 0370-0747 (print)
ISSN 2451-2699 (online) 
Periodicity – biannual

Download original text (EN)

Polymers in Medicine

2019, vol. 49, nr 2, July-December, p. 57–62

doi: 10.17219/pim/116086

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Creative Commons BY-NC-ND 3.0 Open Access

Biomedical application of greenly synthesized silver nanoparticles using the filtrate of Trichoderma viride: Anticancer and immunomodulatory potentials

Bukola Christianah Adebayo-Tayo1,A,C,D,E,F, Gbemisola Elisabeth Ogunleye1,B,C,D,E,F, Omonike Ogbole2,C,F

1 Department of Microbiology, University of Ibadan, Nigeria

2 Department of Pharmacognosy, University of Ibadan, Nigeria

Abstract

Background. Green route biosynthesis of silver nanoparticles using Trichoderma viride (T. viride) filtrate (TVFSNPs) can serve as an alternative to antibiotics and as an effective drug delivery to combat cancer and act as an immune-stimulator.
Objectives. To biosynthesize silver nanoparticles (SNPs) with T. viride filtrate using green route and to characterize and determine the cytotoxic and immunomodulatory potential of nanoparticles.
Material and Methods. Trichoderma viride filtrate was used for biosynthesizing SNPs. The biosynthesized SNPs were characterized using UV-visible spectroscopy, Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM) and energy dispersive X-ray (EDX). The cytotoxic properties against Hep‑2C and rotavirus and the immunomodulatory potential were evaluated.
Results. Trichoderma viride filtrate was able to bio-reduce AgNO3 to SNPs. The surface plasmon resonance peak was at 450 nm. The presence of aldehydes, amino acids, ethers, esters, carboxylic acids, hydroxyl groups, and phenol among others indicates the capping and stabilization of proteins in the nanoparticles. The nanoparticles were spherical with a size of 0.1–10.0 nm. The EDX analysis revealed a strong signal of silver (Ag). The TVFSNPs had a cytotoxic effect on Hep2C and rotavirus in a dose-dependent manner and increased the production of immunoglobulin (Ig) A (IgA) and IgM.
Conclusion. Trichoderma viride filtrate contained some biochemicals that can bio-reduce silver nitrate (AgNO3) for SNPs biosynthesis. The anticancer and immunostimulatory potential justifies the biomedical application and biotechnological relevance of T. viride.

Key words

cytotoxicity, immunomodulation, Trichoderma spp, filtrate, biosynthesized silver nanoparticles

References (27)

  1. Juhi S, Madan MS, Sarika G, Abhijeet S. Emerging role of fungi in nanoparticles synthesis and their applications. World J Pharm Sci. 2014;(3)9:1586–1613.
  2. Amal AAJ, Azzah AG. Biosynthesis of silver nanoparticles by Aspergillus niger, Fusarium oxysporum and Alternaria solani. Afri J Biotechnol. 2015;(4):2170–2174.
  3. Devi TP, Kulanthaivel S, Kamil D, Borah JL, Prabhakaran N. Biosynthesis of silver nanoparticles from Trichoderma species. India J Experimental Biol. 2013;(51)7:543–547.
  4. Nikalje AP. Nanotechnology and its application in medicine. Medici­nal Chem. 2015;5:81–89.
  5. Guangquan L, Dan H, Yongang Q, et al. Fungus-mediated green synthesis of silver nanoparticles using Aspergillus terreus. Intern J Molecular Sci. 2012;(13):466–467.
  6. Sandhu SS, Shukla H, Shukla S. Biosynthesis of silver nanoparticles by endophytic fungi: Its mechanism, characterization techniques and antimicrobial potential. African J Biotechnol. 2017;(16)14:683–698.
  7. Samuels GJ. Trichoderma: Systematics, the sexual state and ecology. Phytopathology. 2006;(96)2:195–206.
  8. Harman GE, Howel CR, Viterbo A, Chet I, Lorito M. Trichoderma species – opportunistic, virulent plant symbionts. Nature Review Microbiol. 2004;(2):43–55.
  9. Druzhinina IS, Komon-Zelazowska M, Ismaiel A, et al. Molecular phylogeny and species delimitation in the section Longibrachiatum of Trichoderma. Fungal Genetic Biol. 2012;(49)5:358–368.
  10. Sivasithamparam K, Ghisalberti E. Secondary metabolism in Trichoderma and Gliocladium. In: Kubicek CP & Harman GE (eds.), Trichoderma and Gliocladium. 1998;1:139-191. London, UK: Taylor & Francis.
  11. Babu K, Pallavi PN. Isolation, identification and mass multiplication of Trichoderma – an important bio-control agent. Inter J Pharmacy Life Sci. 2013;(4)1:2320–2323.
  12. Ottoni CA, Simões MF, Fernandes S, et al. Screening of filamentous fungi for antimicrobial silver nanoparticles synthesis. AMB Express 2017;7:31–41.
  13. Natarajan K, Selvaraj S, Murty VR. Microbial production of silver nanoparticles. DIG J Nanomater Bios. 2010;(5)1:135–140.
  14. Nikhil SS, Mahesh B, Rahul B, et al. Biosynthesis of silver nanoparticles using extract from the producing fungal strain. Process Biochem. 2009;45:939–943.
  15. Sukirtha R, Priyanka KM, Antony JJ, et al. Cytotoxic effect of green synthesized silver nanoparticles using Melia azedarach in vitro HeLa cell lines and lymphoma mice model. Process Biochem. 2010;11:1–34.
  16. Vahabi Ali MG, Karimi, S. Biosynthesis of silver nanoparticles by fungus Trichoderma reesei used for large scale production of Ag nanoparticles. Intern J Nanosci. 2011;(1)1:65–79.
  17. Kanmani P, Lim ST. Synthesis and structural characterization of silver nanoparticles using bacterial activity against food and multidrug resistant pathogens. Process Biochem. 2013;(48):1099–1106.
  18. Sonal SB, Swapnil C, Aniket KG, Mahendra KR. Rapid synthesis of silver nanoparticles from Fusarium oxysporum by optimizing physico-cultural conditions. ScientificWorldJournal. 2013;(10):1155–1167.
  19. Nanda A, Raghavan CM. Antimicrobial efficacy of synthesized AgNPs from exopolysacharides (EPS) produced by Bacillus subtilis of medico-clinical sinks. Intern J Chemical Technol Res. 2014;(6)5:2914–2919.
  20. Pnyabrata M, Absar A, Deendayal M, et al. Fungus-mediated synthesis of silver nanoparticles and their immobilization in the mycelia matrix: A novel biological approach to nanoparticle synthesis. Nano Lett. 2001;(1)10:515–519.
  21. Usha MC, Gladys ARD. Biogenic synthesis of silver nanoparticles by Acacia nilotica and their antibacterial activity. Intern J Scientific Res. 2014;(3)6:27–29.
  22. Vimbela GV, Ngo SM, Fraze C, Yang L, Stout DA. Antibacterial properties and toxicity from metallic nanomaterials. Inter J Nanomed. 2017;(12):3941–3965.
  23. Faria F, Preeti B, Neelam P, Sarika S, Shivam P, Smita RV. Antimicrobial and immunomodulatory efficacy of extracellularly synthesized silver and gold nanoparticles by a novel phosphate solubilizing fungus Bipdaris tetramera. BMC Microbiology. 2015;(15):52.
  24. Raman S, Muthukalingn K, Rajamanickam R, Sound AK, Palanivel K. Derived silver nanoparticles: A novel antitumor agent against Dalton’s ascites lymphoma. Intern J Green Nanotechnol. 2012;(1)3:2–12.
  25. Choi YJ, Lee HW, Lee YS, Shim da M, Seo SW. Differential cytotoxic potential of silver nanoparticles in human ovarian cancer cells and ovarian cancer stem cells. Int J Mol Sci. 2016;(17)12:2077.
  26. Kovacs D, Szoke K, Igaz N, et al. Silver nanoparticles modulate ABC transporter activity and enhance chemotherapy in multidrug resistant cancer. Nanomedicine. 2016;12(3):601–610.
  27. Swarnakar N, Thanki K, Jain S. Effect of co-administration of CoQ10-loaded nanoparticles on the efficacy and cardio-toxicity of doxorubicin-loaded nanoparticles. RSC Adv. 2013;3:146–171.
© Wroclaw Medical University